Imports of U.S. Medicines Top $1 Billion as Seoul Confronts Supply Chain Vulnerabilities
SEOUL, Sept. 17 (Korea Bizwire) — South Korea’s reliance on U.S. pharmaceuticals deepened in 2024, with imports topping $1 billion for the first time, government data showed Tuesday. The trend, fueled by surging demand for cancer treatments and rare disease drugs, has stirred warnings about supply vulnerabilities at a time of heightened trade and tariff tensions [...]

